Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often present with side effects due to hormone hypersecretion. The pathogenesis of these tumors is known to be linked to several genetic diso...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.901435/full |
| _version_ | 1828333437800415232 |
|---|---|
| author | Judy S. Crabtree |
| author_facet | Judy S. Crabtree |
| author_sort | Judy S. Crabtree |
| collection | DOAJ |
| description | Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often present with side effects due to hormone hypersecretion. The pathogenesis of these tumors is known to be linked to several genetic disorders, but sporadic tumors occur due to dysregulation of additional genes that regulate proliferation and metastasis, but also the epigenome. Epigenetic regulation in these tumors includes DNA methylation, chromatin remodeling and regulation by noncoding RNAs. Several large studies demonstrate the identification of epigenetic signatures that may serve as biomarkers, and others identify innovative, epigenetics-based targets that utilize both pharmacological and theranostic approaches towards the development of new treatment approaches. |
| first_indexed | 2024-04-13T21:19:08Z |
| format | Article |
| id | doaj.art-f68c0bc298c94c0991e163fe845203da |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-13T21:19:08Z |
| publishDate | 2022-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-f68c0bc298c94c0991e163fe845203da2022-12-22T02:29:34ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.901435901435Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine TumorsJudy S. CrabtreeGastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often present with side effects due to hormone hypersecretion. The pathogenesis of these tumors is known to be linked to several genetic disorders, but sporadic tumors occur due to dysregulation of additional genes that regulate proliferation and metastasis, but also the epigenome. Epigenetic regulation in these tumors includes DNA methylation, chromatin remodeling and regulation by noncoding RNAs. Several large studies demonstrate the identification of epigenetic signatures that may serve as biomarkers, and others identify innovative, epigenetics-based targets that utilize both pharmacological and theranostic approaches towards the development of new treatment approaches.https://www.frontiersin.org/articles/10.3389/fonc.2022.901435/fullDNA methylationneuroendocrinehistone modificationmiRNApancreatic |
| spellingShingle | Judy S. Crabtree Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors Frontiers in Oncology DNA methylation neuroendocrine histone modification miRNA pancreatic |
| title | Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors |
| title_full | Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors |
| title_fullStr | Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors |
| title_full_unstemmed | Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors |
| title_short | Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors |
| title_sort | epigenetic regulation in gastroenteropancreatic neuroendocrine tumors |
| topic | DNA methylation neuroendocrine histone modification miRNA pancreatic |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.901435/full |
| work_keys_str_mv | AT judyscrabtree epigeneticregulationingastroenteropancreaticneuroendocrinetumors |